Ajay Yadlapati

Ajay Yadlapati

Auto-generated profile, based on publicly available information

Ajay Yadlapati

Division of Cardiology, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2015 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
AYAjay Yadlapati
Ajay Yadlapati
CGChristopher Groh
Christopher Groh
SMS. Chris Malaisrie
S. Chris Malaisrie
MGMark Gajjar
Mark Gajjar
JKJane Kruse
Jane Kruse
RPRod Passman
Rod Passman

1 April 2014 in The American Journal of Cardiology
Verified
Journal Article
Closed access
AYAjay Yadlapati
Ajay Yadlapati
CGChristopher Groh
Christopher Groh
RPRod Passman
Rod Passman

22 December 2015 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
ATAlexander P. Taylor
Alexander P. Taylor
AYAjay Yadlapati
Ajay Yadlapati
AAAdin‐Cristian Andrei
Adin‐Cristian Andrei
ZLZhi Li
Zhi Li
CCColleen Clennon
Colleen Clennon
JPJyothy J. Puthumana
Jyothy J. Puthumana
Background: No medical therapy has been proven to prevent the progression of aortic dilatation in bicuspid aortic valve (BAV) disease, and prophylactic aortic surgery remains the mainstay of treatment.Hypothesis: Among patients with BAV disease who are referred for surgery, preoperative statin use is associated with decreased odds of ascending aortic dilatation.Methods: We reviewed all BAV patients who underwent aortic valve and/or aortic surgery at our center between April 2004 and December 2013. Aortic diameter (AD), defined as the maximum ascending aortic dimension, was determined by magnetic resonance imaging, computed tomography, or echocardiography. Patients were divided into 2 groups: maximal AD <4.5 cm or ≥4.5 cm. The association between preoperative statin use and aortic dilatation was assessed using multivariable logistic regression modeling.Results: Of 680 consecutive patients, 405 (60%) had AD <4.5 cm (mean age, 60 ± 14 years; 45% on statins), whereas 275 (40%) had AD ≥4.5 cm (mean age, 54 ± 13 years; 35% on statins) at the time of surgery. After adjusting for age, body surface area, sex, hypertension, aortic stenosis, severity of aortic regurgitation, and use of angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, and β‐blockers, patients with AD ≥4.5 cm had 0.66× lower odds (95% confidence interval: 0.45‐0.96) of being on preoperative statins compared with those with AD <4.5 cm (P = 0.029).Conclusions: In a retrospective study of BAV patients referred for surgery, preoperative statin use was associated with lower odds of clinically significant ascending aortic dilatation.

1 August 2016 in Texas Heart Institute Journal
Verified
Journal Article
Closed access
RWRamsey M. Wehbe
Ramsey M. Wehbe
AYAjay Yadlapati
Ajay Yadlapati
Article Citation: Ramsey M. Wehbe and Ajay Yadlapati (2016) Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future. Texas Heart Institute Journal: August 2016, Vol. 43, No. 4, pp. 287-290. doi: http://dx.doi.org/10.14503/THIJ-16-5785

3 September 2015 in International Cardiovascular Forum Journal
Verified
Journal Article
Open access
PDF file
RWRamsay Wehbe
Ramsay Wehbe
ECEric Curcio
Eric Curcio
MGMark Gajjar
Mark Gajjar
AYAjay Yadlapati
Ajay Yadlapati
Technology and Its Influence on the Doctor-Patient Relationship

12 September 2013 in Journal of Transplantation
Verified
Journal Article
Open access
PDF file
AYAjay Yadlapati
Ajay Yadlapati
JLJoseph P. Lynch
Joseph P. Lynch
RSRajan Saggar
Rajan Saggar
DRDavid Ross
David Ross
JBJohn A. Belperio
John A. Belperio
JAJamil Aboulhosn
Jamil Aboulhosn
Background. Orthotopic lung transplantation is now widely performed in patients with advanced lung disease. Patients with moderate or severe ventricular systolic dysfunction are typically excluded from lung transplantation; however, there is a paucity of data regarding the prognostic significance of abnormal left ventricular diastolic function and elevated pretransplant pulmonary pressures.Methods. We reviewed the characteristics of 111 patients who underwent bilateral and unilateral lung transplants from 200 to 2009 in order to evaluate the prognostic significance of preoperative markers of diastolic function, including invasively measured pulmonary capillary wedge pressure (PCWP) and echocardiographic variables of diastolic dysfunction including mitralA>EandA′>E′.Results. Out of 111 patients, 62 were male (56%) and average age was 54.0 ± 10.5 years. Traditional echocardiographic Doppler variables of abnormal diastolic function, includingA′>E′andA>E, did not predict adverse events (P=0.49). Mildly elevated pretransplant PCWP (16–20 mmHg) and moderately/severely elevated PCWP (>20 mmHg) were not associated with adverse clinical events after transplant (P=0.30). Additionally, all clinical endpoints did not show any statistical significance between the two groups.Conclusions. Pre-lung transplant invasive and echocardiographic findings of elevated pulmonary pressures and abnormal left ventricular diastolic function are not predictive of adverse posttransplant clinical events.